Translation
Notice: This document is an excerpt translation of the original Japanese document and is only for reference purposes. In the event of any discrepancy between this translated document and the original Japanese document, the latter shall prevail.
Summary of Consolidated Financial Results for the Six Months Ended March 31, 2021 (Based on Japanese GAAP)
May 14, 2021 | ||||||||||||||||||||||||
Company name: | euglena Co., Ltd. | |||||||||||||||||||||||
Stock exchange listing: | Tokyo | |||||||||||||||||||||||
Stock code: | 2931 | URL http://www.euglena.jp/ | ||||||||||||||||||||||
Representative: | CEO and Representative Director | Mitsuru Izumo | ||||||||||||||||||||||
Inquiries: | COO and Director | Akihiko Nagata | TEL | 03(3454)4907 | ||||||||||||||||||||
Scheduled date to file Quarterly Securities Report: | May 14, 2021 | |||||||||||||||||||||||
Scheduled date to commence dividend payments: | - | |||||||||||||||||||||||
Preparation of supplementary material on quarterly financial results: | Yes | |||||||||||||||||||||||
Holding of quarterly financial results meeting: | Yes | |||||||||||||||||||||||
(Amounts less than one million yen are rounded down) | ||||||||||||||||||||||||
1. Consolidated financial results for the six months ended March 31, 2021 (from October 1, 2020 to March 31, 2021) | ||||||||||||||||||||||||
(1) Consolidated operating results (cumulative) | Percentages indicate year-on-year changes | |||||||||||||||||||||||
Net sales | Operating profit | Ordinary profit | Profit attributable to | |||||||||||||||||||||
owners of parent | ||||||||||||||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | |||||||||||||||||
Six months ended March 31, 2021 | 7,737 | 27.2 | (508) | - | (127) | - | (196) | - | ||||||||||||||||
Six months ended March 31, 2020 | 6,081 | (12.1) | (360) | - | (137) | - | (143) | - | ||||||||||||||||
Note: Comprehensive income | Six months ended March 31, 2021 | ¥(199) million | [-%] | |||||||||||||||||||||
Six months ended March 31, 2020 | ¥(147) million | [-%] | ||||||||||||||||||||||
Earnings per share | Diluted earnings per share | |||||||||||||||||||||||
Yen | Yen | |||||||||||||||||||||||
Six months ended March 31, 2021 | (2.10) | - | ||||||||||||||||||||||
Six months ended March 31, 2020 | (1.55) | - | ||||||||||||||||||||||
(2) Consolidated financial position | ||||||||||||||||||||||||
Total assets | Net assets | Equity ratio | ||||||||||||||||||||||
Millions of yen | Millions of yen | % | ||||||||||||||||||||||
As of March 31, 2021 | 21,355 | 11,067 | 51.8 | |||||||||||||||||||||
As of September 30, 2020 | 15,351 | 9,386 | 61.0 | |||||||||||||||||||||
Reference: Equity | As of March 31, 2021 | ¥11,057 | million | |||||||||||||||||||||
As of September 30, 2020 | ¥9,363 | million | ||||||||||||||||||||||
2. Cash dividends | ||||||||||||||||||||||||
Annual dividends per share | ||||||||||||||||||||||||
1st quarter-end | 2nd quarter-end | 3rd quarter-end | Fiscal year-end | Total | ||||||||||||||||||||
Yen | Yen | Yen | Yen | Yen | ||||||||||||||||||||
Year ended September 30, 2020 | - | 0.00 | - | 0.00 | 0.00 | |||||||||||||||||||
Year ending September 30, 2021 | - | 0.00 | ||||||||||||||||||||||
Year ending September 30, 2021 | - | 0.00 | 0.00 | |||||||||||||||||||||
(Forecast) | ||||||||||||||||||||||||
Note: Revision to cash dividend forecasts most recently announced: No |
1
3. Forecast of consolidated financial results for the year ending September 30, 2021 (from October 1, 2020 to September 30, 2021)
Percentages indicate year-on-year changes
Net sales | Operating profit | Ordinary profit | Profit attributable to | Earnings per share | ||||||||
owners of parent | ||||||||||||
Millions of yen | % | Millions of yen | % | Millions of yen | % | Millions of yen | % | Yen | ||||
Full year | 22,000 | 65.2 | - | - | - | - | - | - | - | |||
Note: Revision to consolidated financial results forecast most recently announced: Yes | ||||||||||||
(Reference) Adjusted EBITDA | ||||||||||||
Previous forecast: | Year ending September 30, 2021 | ¥(630) | million | |||||||||
Amended forecast: | Year ending September 30, 2021 | ¥(200) | million |
Net sales and adjusted EBITDA are announced in the financial results forecast for the fiscal year ending September 30, 2021. Adjusted EBITDA = EBITDA(Operating profit + Amortization of goodwill and Depreciation) + Subsidy income + Stock-related remuneration
4. Notes | ||||||
(1) | Changes in significant subsidiaries during the six months ended March 31, 2021 | No | ||||
(changes in specified subsidiaries resulting in the change in scope of consolidation): | ||||||
(2) | Application of special accounting methods for preparing quarterly consolidated financial statements: | No | ||||
(3) | Changes in accounting policies, changes in accounting estimates, and restatement of prior period financial statements | |||||
Changes in accounting policies due to revisions to accounting standards and other regulations: | No | |||||
Changes in accounting policies due to other reasons: | No | |||||
Changes in accounting estimates: | No | |||||
Restatement of prior period financial statements: | No | |||||
(4) | Number of issued shares (common shares) | |||||
Total number of issued shares at the end of the period (including treasury shares) | ||||||
As of March 31, 2021 | 95,227,862 shares | As of September 30, 2020 | 93,153,322 shares | |||
Number of treasury shares at the end of the period | ||||||
As of March 31, 2021 | 20,431 shares | As of September 30, 2020 | 56,459 shares | |||
Average number of shares during the period (cumulative from the beginning of the fiscal year) | ||||||
Six months ended March 31, 2021 | 93,464,484 shares | Six months ended March 31, 2020 | 92,848,942 shares |
- Quarterly financial results reports are exempt from quarterly review conducted by certified public accountants or an audit corporation.
-
Proper use of financial results forecast, and other special matters
The forward-looking statements, including the earnings forecasts, shown in this document are based on information currently available to the Company and on certain assumptions deemed to be reasonable. These statements do not purport that the Company pledges to realize such statements. Actual results may differ substantially due to various factors.
2
Attachments
- Original document
- Permalink
Disclaimer
Euglena Co. Ltd. published this content on 24 May 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 24 May 2021 06:32:02 UTC.